Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2013
06/04/2013CA2545660C Heterocyclic inhibitors of mek and methods of use thereof
06/04/2013CA2545659C Bicyclic inhibitors of mek
05/2013
05/30/2013WO2013077406A1 Aromatic amine derivative, material for organic electroluminescent element, and organic electroluminescent element
05/30/2013WO2013075399A1 Unsaturated 5-membered benzo-heterocyclic compound or pharmaceutical salts thereof, and preparation method, pharmaceutical composition and use thereof
05/30/2013US20130137880 Process for producing optically active 3-substituted-3-formyl-2-hydroxypropanoic acid compound
05/30/2013US20130137852 Novel compounds as dpp-iv inhibitors and process for preparation thereof
05/30/2013US20130137686 Benzene, pyridine, and pyridazine derivatives
05/30/2013US20130136832 Methods of preservation
05/29/2013EP2597097A1 Substituted indoles, antiviral active component, method for producing and using same
05/29/2013CN103121965A Salts of indolone derivatives
05/29/2013CN101941939B Polyfunctional carbazole derivative oxime ester compound and preparation method and light polymerization initiator thereof
05/28/2013US8450398 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
05/28/2013US8450361 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
05/28/2013US8450347 Administering a protein fraction, digestible carbohydrates, and a combination of folate, and one of vitamin B6 and vitamin B12.
05/28/2013US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
05/28/2013CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives
05/28/2013CA2539823C Hemiasterlin derivatives and uses thereof
05/28/2013CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
05/23/2013WO2013074459A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
05/23/2013WO2013073896A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/23/2013WO2013072935A2 Process for the preparation of silodosin
05/23/2013WO2013071880A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists
05/23/2013WO2013019079A9 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases
05/23/2013WO2012051318A8 Sulphonamide compounds and methods of making and using same
05/23/2013US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/23/2013US20130131114 Novel alkene oxindole derivatives
05/23/2013US20130131084 Use of derivatives of indoles for the treatment of cancer
05/23/2013US20130131061 Novel Estrogen Receptor Ligands
05/23/2013US20130129812 Novel compositions and methods for treating cancer
05/23/2013US20130129811 Cationic lipid
05/23/2013CA2856100A1 Nitrogen-containing fused ring compounds as crth2 antagonists
05/23/2013CA2855759A1 Tricyclic compounds, compositions comprising them and uses thereof
05/22/2013EP2595208A1 Light emitting element
05/22/2013CN103119125A Novel organic electroluminescent compounds and organic electroluminescent devices including the same
05/22/2013CN103119015A Processes for the resolution of nitrogen substituted (S) - 5 -alkoxy- 2 -aminotetralin derivatives
05/22/2013CN103113552A 一种松香基扩链剂及其制备方法 Provide a rosin-based chain extender and its preparation method
05/22/2013CN103113289A Organic electroluminescent material containing benzanthracene derivative and preparation method of organic electroluminescent material
05/22/2013CN103113288A Synthesis method of octahydro-cyclopenta[c]pyrrole carboxylic acid derivative
05/22/2013CN103113287A Method for preparing mecarbinate (1,2-dimethyl-5hydroxy-1H-indol-3-ethyl carboxylate)
05/22/2013CN103113286A Method for separating amino acid enantiomer on basis of silicon dioxide nanochannels
05/22/2013CN103113285A Indole compound and application thereof as HIV-1 reverse transcriptase inhibitor
05/22/2013CN103113284A Half cyanine dye compound, preparation method and application of half cyanine dye compound
05/22/2013CN103113283A Method for preparing hemicyanine plastocyanin temperature-sensitive molecular optical probe containing electron-donating group
05/22/2013CN103113282A Preparation method for electrondrawing group containing semi-cyanine temperature-sensitive molecular optical probe
05/22/2013CN103113281A Benzanthracene efficient organic light emitting material and preparation method
05/22/2013CN103113177A Preparation method of amide
05/22/2013CN102134214B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
05/22/2013CN102001987B Heteroarylamine compound, organic light-emitting device and panel display device
05/22/2013CN101941937B Method for concentrating 5-hydroxytryptophan
05/22/2013CN101687786B Hydroxylamine compounds and methods of their use
05/22/2013CN101535256B Aromatic amine derivative and organic electroluminescent element using the same
05/21/2013US8445697 Squarylium dyes including an anchoring group
05/21/2013US8445529 Indole derivative having, carbamoyl group, ureido group and substituted oxy group
05/21/2013US8445528 Dendrimer conjugates
05/21/2013US8445491 Wnt protein signalling inhibitors
05/21/2013US8445481 Scaffold-diversified pyrrolidinone derivatives and their use
05/21/2013CA2401821C Amino acid derivatives as hiv aspartyl protease inhibitors
05/16/2013WO2013067710A1 Nampt inhibitors
05/16/2013US20130123492 Acenaphtho heterocyclic compound and application thereof
05/16/2013US20130123326 Allosteric binding compounds
05/16/2013US20130119355 Styryl-based compound, composition containing styryl-based compound, and organic light emitting diode including styryl-based compound
05/16/2013CA2855510A1 Nampt inhibitors
05/15/2013EP2590944A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
05/15/2013EP2590647A2 Pro-neurogenic compounds
05/15/2013CN103108865A Processes and intermediates
05/15/2013CN103108864A Arylosulfonamides for the treatment of cns diseases
05/15/2013CN103102389A Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease
05/15/2013CN103102352A Tyrosine kinase inhibitor indolinone derivative
05/15/2013CN103102299A Benzanthracene derivative and preparation method thereof and organic electroluminescence material prepared by same
05/15/2013CN103102232A Styryl-based compound, composition containing styryl-based compound, and organic light emitting diode including styryl-based compound
05/15/2013CN103102228A Preparation method of aryl eneyne compound
05/15/2013CN101508670B Compound for forming organic film, and organic light emitting device and flat panel display device including the same
05/14/2013US8440840 Dye including an anchoring group in its molecular structure
05/14/2013US8440711 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
05/14/2013US8440710 HSL inhibitors useful in the treatment of diabetes
05/14/2013US8440684 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators
05/14/2013US8440169 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins
05/14/2013CA2716369C Phenoxypropylamine compounds
05/14/2013CA2583333C Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
05/14/2013CA2486015C Novel amino acid derivative and sweetening agent
05/10/2013WO2013066757A1 Polyetherimides, methods of manufacture, and articles formed therefrom
05/10/2013WO2013065725A1 Phthalamide derivative, pesticide for agricultural and horticultural applications which comprises said derivative, and method of utilizing said pesticide
05/10/2013WO2013064538A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
05/10/2013CA2853006A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
05/09/2013US20130116318 Enzyme Inhibitors
05/09/2013US20130116204 (methylsulfonyl) ethyl benzene isoindoline derivatives and their pharmaceutical uses
05/09/2013US20130113367 Heterocyclic compound and organic light-emitting device including the same
05/09/2013US20130112948 Heterocyclic compound and organic light-emitting diode including the same
05/08/2013EP2589591A1 Compound with carbazole ring structure and organic electroluminescent element
05/08/2013EP2588104A1 Isoindolone m1 receptor positive allosteric modulators
05/08/2013CN103097354A Substituted benzamide compounds
05/08/2013CN103097353A Novel immunomodulator and anti inflammatory compounds
05/08/2013CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/08/2013CN103086953A Heterocyclic compound and organic light-emitting device including the same
05/08/2013CN103086952A Preparation method of 4,4'-[(9-butyl-9H-carbazole-3-)methylene]bis[N-methyl-N-phenyl]aniline
05/08/2013CN103086951A Environmentally-friendly preparation method of high-purity tetrahydrocarbazole
05/08/2013CN103086950A Carbazolyl-based organic electroluminescence compound
05/08/2013CN103086949A Carbazole derivatives and organic light emitting diodes comprising the same
05/08/2013CN103086948A Preparation method of (S,S,S)-2-azabicyclo[3,3,0]octane-3-carboxylic acid
05/08/2013CN103086947A Phthalimide compounds with antiangiogenic activity and purpose thereof
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 458